These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Developing live vaccines against plague. Sun W; Roland KL; Curtiss R J Infect Dev Ctries; 2011 Sep; 5(9):614-27. PubMed ID: 21918302 [TBL] [Abstract][Full Text] [Related]
23. Cell-mediated immune response and Th/Th cytokine profile of B-T constructs of F1 and V antigen of Yersinia pestis. Gupta G; Khan AA; Rao DN Scand J Immunol; 2010 Mar; 71(3):186-98. PubMed ID: 20415784 [TBL] [Abstract][Full Text] [Related]
24. [Effect of immune modulation on immunogenic and protective activity of a live plague vaccine]. Karal'nik BV; Ponomareva TS; Deriabin PN; Denisova TG; Mel'nikova NN; Tugambaev TI; Atshabar BB; Zakarian SB Zh Mikrobiol Epidemiol Immunobiol; 2014; (6):108-12. PubMed ID: 25816525 [TBL] [Abstract][Full Text] [Related]
25. Immunogenicity and efficacy of an anthrax/plague DNA fusion vaccine in a mouse model. Albrecht MT; Eyles JE; Baillie LW; Keane-Myers AM FEMS Immunol Med Microbiol; 2012 Aug; 65(3):505-9. PubMed ID: 22515653 [TBL] [Abstract][Full Text] [Related]
26. CpG oligodeoxynucleotides augment the murine immune response to the Yersinia pestis F1-V vaccine in bubonic and pneumonic models of plague. Amemiya K; Meyers JL; Rogers TE; Fast RL; Bassett AD; Worsham PL; Powell BS; Norris SL; Krieg AM; Adamovicz JJ Vaccine; 2009 Apr; 27(16):2220-9. PubMed ID: 19428836 [TBL] [Abstract][Full Text] [Related]
27. Immunogenicity of the rF1+rV vaccine for plague with identification of potential immune correlates. Williamson ED; Flick-Smith HC; Waters E; Miller J; Hodgson I; Le Butt CS; Hill J Microb Pathog; 2007 Jan; 42(1):11-21. PubMed ID: 17107769 [TBL] [Abstract][Full Text] [Related]
28. Protein microarray for profiling antibody responses to Yersinia pestis live vaccine. Li B; Jiang L; Song Q; Yang J; Chen Z; Guo Z; Zhou D; Du Z; Song Y; Wang J; Wang H; Yu S; Wang J; Yang R Infect Immun; 2005 Jun; 73(6):3734-9. PubMed ID: 15908403 [TBL] [Abstract][Full Text] [Related]
30. Different strategies for preparation of non-tagged rV270 protein and its efficacy against Yersinia pestis challenge. Wang W; Qi ZZ; Zhang QW; Wu BC; Zhu ZW; Yang YH; Cui BZ; Dai RX; Qiu YF; Wang ZY; Guo ZB; Shi TX; Wang H; Yang RF; Wang XY Biomed Environ Sci; 2010 Oct; 23(5):333-40. PubMed ID: 21112480 [TBL] [Abstract][Full Text] [Related]
31. Kinetics of the immune response to the (F1+V) vaccine in models of bubonic and pneumonic plague. Williamson ED; Stagg AJ; Eley SM; Taylor R; Green M; Jones SM; Titball RW Vaccine; 2007 Jan; 25(6):1142-8. PubMed ID: 17101198 [TBL] [Abstract][Full Text] [Related]
32. [The activity of NK and K cells in people vaccinated and revaccinated against plague]. Pchelintsev SIu; Solokhin EV; Iurov SV; Uraeva VI; Riazantsev SV; Afanas'ev SS; Savel'ev AP; Vorob'ev AA Zh Mikrobiol Epidemiol Immunobiol; 1994; (2):99-102. PubMed ID: 8017139 [TBL] [Abstract][Full Text] [Related]
33. [Electrophoretic mobility and energy charge of the adenyl system of blood lymphocytes in guinea pigs immunized against plague with strain Yersinia pestis ev subcultures with different immunogenicity]. Anisimova TI; Saiapina LV; Korsukov VN Zh Mikrobiol Epidemiol Immunobiol; 2005; (5):63-6. PubMed ID: 16279538 [TBL] [Abstract][Full Text] [Related]
34. Stat 4 but not Stat 6 mediated immune mechanisms are essential in protection against plague. Elvin SJ; Williamson ED Microb Pathog; 2004 Oct; 37(4):177-84. PubMed ID: 15458778 [TBL] [Abstract][Full Text] [Related]
36. [Lectin of Yersinia pestis vaccine strain EV and its immunological properties]. Tikhomirova EI; Zadnova SP; Volokh OA; Karpunina LV; Shcherbakov AA Zh Mikrobiol Epidemiol Immunobiol; 2003; (1):51-5. PubMed ID: 12630354 [TBL] [Abstract][Full Text] [Related]
37. [Study of protective properties of antigen-containing liposomes of different lipid composition in plague]. Zakrevskiĭ VI; Plekhanova NG Vestn Akad Med Nauk SSSR; 1990; (8):41-4. PubMed ID: 2275277 [TBL] [Abstract][Full Text] [Related]
38. The F1 and V subunit vaccine protects against plague in the absence of IL-4 driven immune responses. Elvin SJ; Williamson ED Microb Pathog; 2000 Oct; 29(4):223-30. PubMed ID: 10993741 [No Abstract] [Full Text] [Related]
39. T cells play an essential role in anti-F1 mediated rapid protection against bubonic plague. Levy Y; Flashner Y; Tidhar A; Zauberman A; Aftalion M; Lazar S; Gur D; Shafferman A; Mamroud E Vaccine; 2011 Sep; 29(40):6866-73. PubMed ID: 21803090 [TBL] [Abstract][Full Text] [Related]